|Letters of Intent were due Thursday, January 31, 2019, by 5:00 p.m. ET.
Those selected to submit a full application were notified by Tuesday, February 26, 2019.
Full applications were due Wednesday, April 24, 2019, by 5:00 p.m. ET.
In the Treatment of Anxiety in Children, Adolescents, and/or Young Adults PFA, we seek to fund high quality clinical studies that compare the effectiveness of evidence-based clinical strategies to treat anxiety disorders in children, adolescents, and/or young adults. Clinical strategies to be studied may include pharmacological interventions, psychological interventions, or a combination of both. Each proposed comparator must be clearly defined, evidence-based, widely available, and appropriate for the age range and clinical severity of the study population. The proposed study population should include patients with a confirmed clinical diagnosis of a primary anxiety disorder and who are between 7 and 25 years of age. Studies with a minimum follow-up period of nine months from baseline are sought, with one year of follow-up preferred. In addition, all studies funded through this initiative must include robust sample sizes of at least 300 participants, with sufficient power demonstrated to conduct the proposed analyses.